Hypericum perforatum

DRUG3 trials

Sponsors

National Center for Complementary and Integrative Health (NCCIH), Alliance for Clinical Trials in Oncology

Conditions

Adult Solid TumorAttention Deficit Hyperactivity DisorderBreast CancerContraceptionHead and Neck CancerKidney and Urinary CancerMale Reproductive CancerThorax and Respiratory Cancer

Phase 2

Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)

CompletedNCT00100295

National Center for Complementary and Integrative Health (NCCIH)Attention Deficit Hyperactivity Disorder

Start: 2005-02-28End: 2006-11-30Updated: 2007-10-26

Phase 3

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

WithdrawnNCT00041171

Alliance for Clinical Trials in OncologyAdult Solid Tumor, Breast Cancer, Head and Neck Cancer +3

Updated: 2016-07-12

Unknown Phase

Effects of St. John's Wort on the Effectiveness of Oral Contraceptives

CompletedNCT00026013

National Center for Complementary and Integrative Health (NCCIH)Contraception

Start: 2002-01-31End: 2004-01-31Target: 25Updated: 2006-08-18

Related Papers

Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial.

2008-06-0134 citations